- Report
- April 2025
- 250 Pages
Global
From €4029EUR$4,490USD£3,536GBP
- Report
- April 2025
- 200 Pages
Global
From €4029EUR$4,490USD£3,536GBP
- Report
- March 2025
- 200 Pages
Global
From €4029EUR$4,490USD£3,536GBP
- Report
- February 2025
- 200 Pages
Global
From €4029EUR$4,490USD£3,536GBP
- Report
- February 2025
- 200 Pages
Global
From €4029EUR$4,490USD£3,536GBP
- Report
- June 2025
- 400 Pages
Global
From €4441EUR$4,949USD£3,898GBP
- Report
- July 2025
- 350 Pages
Global
From €4441EUR$4,949USD£3,898GBP
- Report
- June 2025
- 270 Pages
Global
From €4482EUR$4,995USD£3,934GBP
From €6730EUR$7,500USD£5,907GBP
- Report
- May 2025
- 52 Pages
Global
From €6730EUR$7,500USD£5,907GBP
- Report
- February 2025
Japan, United States, ... Japan, United States, Europe, Global
From €3365EUR$3,750USD£2,953GBP
- Report
- September 2025
- 126 Pages
Europe
From €5380EUR$5,995USD£4,721GBP
- Report
- September 2025
- 100 Pages
North America
From €5380EUR$5,995USD£4,721GBP
- Report
- September 2025
- 127 Pages
Asia Pacific
From €5380EUR$5,995USD£4,721GBP
- Report
- February 2025
Latin America
From €8525EUR$9,500USD£7,482GBP
- Report
- February 2025
Middle East
From €4038EUR$4,500USD£3,544GBP
- Report
- February 2025
North America, Mexico, ... North America, Mexico, Canada
From €2198EUR$2,450USD£1,930GBP
- Report
- February 2025
France, Germany, ... France, Germany, Italy, Spain, United Kingdom, Europe
From €2557EUR$2,850USD£2,245GBP
- Report
- February 2025
United States
From €1301EUR$1,450USD£1,142GBP
- Report
- April 2023
- 75 Pages
Global
From €3365EUR$3,750USD£2,953GBP

Hemostasis is a process that helps to stop bleeding and is a part of the larger coagulation and hemostasis testing market. This market includes products and services used to diagnose and monitor bleeding and clotting disorders. Tests used in this market include prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), fibrinogen, and platelet aggregation. These tests are used to diagnose and monitor conditions such as hemophilia, thrombocytopenia, and von Willebrand disease.
The coagulation and hemostasis testing market is driven by the increasing prevalence of bleeding and clotting disorders, the growing demand for point-of-care testing, and the development of new technologies. Companies in this market include Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Sysmex Corporation, and Alere Inc. Show Less Read more